Selected research
Industry Research
Calming and Sleeping Industry Research Report 2026
Market perspective
The global Calming and Sleeping market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Calming and Sleeping is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Calming and Sleeping is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Calming and Sleeping is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Calming and Sleeping include Teva Pharmaceutical, Johnson & Johnson, Eli Lilly, AstraZeneca, Sunovion Pharmaceuticals, Roscoe Medical, Durect, Collegium Pharmaceutical and Cara Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Calming and Sleeping market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Calming and Sleeping Market by Company
Teva Pharmaceutical
Johnson & Johnson
Eli Lilly
AstraZeneca
Sunovion Pharmaceuticals
Roscoe Medical
Durect
Collegium Pharmaceutical
Cara Therapeutics
Acura Pharmaceuticals
Calming and Sleeping Segment by Type
Medications
Sleep Laboratories
Sleep Apnea Devices
Mattresses and Pillows
Prescriptions
Over-The-Counter (OTC)
Calming and Sleeping Segment by Application
Restless Leg Syndrome (RLS)
Narcolepsy
Sleepwalking
Bruxism
Insomnia
Sleep apnea
Calming and Sleeping Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calming and Sleeping market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Calming and Sleeping and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calming and Sleeping.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Calming and Sleeping by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Calming and Sleeping in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medications
- Sleep Laboratories
- Sleep Apnea Devices
- Mattresses and Pillows
- Prescriptions
- Over-The-Counter (OTC)
Applications
- Restless Leg Syndrome (RLS)
- Narcolepsy
- Sleepwalking
- Bruxism
- Insomnia
- Sleep apnea
Companies covered
- Teva Pharmaceutical
- Johnson & Johnson
- Eli Lilly
- AstraZeneca
- Sunovion Pharmaceuticals
- Roscoe Medical
- Durect
- Collegium Pharmaceutical
- Cara Therapeutics
- Acura Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Calming and Sleeping Market Size (2021-2032)
- 2.2.2 Global Calming and Sleeping Sales (2021-2032)
- 2.2.3 Global Calming and Sleeping Market Average Price (2021-2032)
- 2.3 Calming and Sleeping by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medications
- 2.3.3 Sleep Laboratories
- 2.3.4 Sleep Apnea Devices
- 2.3.5 Mattresses and Pillows
- 2.3.6 Prescriptions
- 2.3.7 Over-The-Counter (OTC)
- 2.4 Calming and Sleeping by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Restless Leg Syndrome (RLS)
- 2.4.3 Narcolepsy
- 2.4.4 Sleepwalking
- 2.4.5 Bruxism
- 2.4.6 Insomnia
- 2.4.7 Sleep apnea
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Calming and Sleeping Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Calming and Sleeping Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Calming and Sleeping Revenue of Manufacturers (2021-2026)
- 3.4 Global Calming and Sleeping Average Price by Manufacturers (2021-2026)
- 3.5 Global Calming and Sleeping Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Calming and Sleeping, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Calming and Sleeping, Product Type & Application
- 3.8 Global Manufacturers of Calming and Sleeping, Established Date
- 3.9 Global Calming and Sleeping Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Calming and Sleeping Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Calming and Sleeping Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly Calming and Sleeping Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Calming and Sleeping Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Sunovion Pharmaceuticals
- 4.5.1 Sunovion Pharmaceuticals Company Information
- 4.5.2 Sunovion Pharmaceuticals Business Overview
- 4.5.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sunovion Pharmaceuticals Calming and Sleeping Product Portfolio
- 4.5.5 Sunovion Pharmaceuticals Recent Developments
- 4.6 Roscoe Medical
- 4.6.1 Roscoe Medical Company Information
- 4.6.2 Roscoe Medical Business Overview
- 4.6.3 Roscoe Medical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Roscoe Medical Calming and Sleeping Product Portfolio
- 4.6.5 Roscoe Medical Recent Developments
- 4.7 Durect
- 4.7.1 Durect Company Information
- 4.7.2 Durect Business Overview
- 4.7.3 Durect Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Durect Calming and Sleeping Product Portfolio
- 4.7.5 Durect Recent Developments
- 4.8 Collegium Pharmaceutical
- 4.8.1 Collegium Pharmaceutical Company Information
- 4.8.2 Collegium Pharmaceutical Business Overview
- 4.8.3 Collegium Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Collegium Pharmaceutical Calming and Sleeping Product Portfolio
- 4.8.5 Collegium Pharmaceutical Recent Developments
- 4.9 Cara Therapeutics
- 4.9.1 Cara Therapeutics Company Information
- 4.9.2 Cara Therapeutics Business Overview
- 4.9.3 Cara Therapeutics Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cara Therapeutics Calming and Sleeping Product Portfolio
- 4.9.5 Cara Therapeutics Recent Developments
- 4.10 Acura Pharmaceuticals
- 4.10.1 Acura Pharmaceuticals Company Information
- 4.10.2 Acura Pharmaceuticals Business Overview
- 4.10.3 Acura Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Acura Pharmaceuticals Calming and Sleeping Product Portfolio
- 4.10.5 Acura Pharmaceuticals Recent Developments
5 Global Calming and Sleeping Market Scenario by Region
- 5.1 Global Calming and Sleeping Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Calming and Sleeping Sales by Region: 2021-2032
- 5.2.1 Global Calming and Sleeping Sales by Region: 2021-2026
- 5.2.2 Global Calming and Sleeping Sales by Region: 2027-2032
- 5.3 Global Calming and Sleeping Revenue by Region: 2021-2032
- 5.3.1 Global Calming and Sleeping Revenue by Region: 2021-2026
- 5.3.2 Global Calming and Sleeping Revenue by Region: 2027-2032
- 5.4 North America Calming and Sleeping Market Facts & Figures by Country
- 5.4.1 North America Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Calming and Sleeping Sales by Country (2021-2032)
- 5.4.3 North America Calming and Sleeping Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Calming and Sleeping Market Facts & Figures by Country
- 5.5.1 Europe Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Calming and Sleeping Sales by Country (2021-2032)
- 5.5.3 Europe Calming and Sleeping Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Calming and Sleeping Market Facts & Figures by Country
- 5.6.1 Asia Pacific Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Calming and Sleeping Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Calming and Sleeping Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Calming and Sleeping Market Facts & Figures by Country
- 5.7.1 South America Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Calming and Sleeping Sales by Country (2021-2032)
- 5.7.3 South America Calming and Sleeping Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Calming and Sleeping Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Calming and Sleeping Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Calming and Sleeping Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Calming and Sleeping Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Calming and Sleeping Sales by Type (2021-2032)
- 6.1.1 Global Calming and Sleeping Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Calming and Sleeping Sales Market Share by Type (2021-2032)
- 6.2 Global Calming and Sleeping Revenue by Type (2021-2032)
- 6.2.1 Global Calming and Sleeping Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Calming and Sleeping Revenue Market Share by Type (2021-2032)
- 6.3 Global Calming and Sleeping Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Calming and Sleeping Sales by Application (2021-2032)
- 7.1.1 Global Calming and Sleeping Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Calming and Sleeping Sales Market Share by Application (2021-2032)
- 7.2 Global Calming and Sleeping Revenue by Application (2021-2032)
- 7.2.1 Global Calming and Sleeping Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Calming and Sleeping Revenue Market Share by Application (2021-2032)
- 7.3 Global Calming and Sleeping Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Calming and Sleeping Value Chain Analysis
- 8.1.1 Calming and Sleeping Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Calming and Sleeping Production Mode & Process
- 8.2 Calming and Sleeping Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Calming and Sleeping Distributors
- 8.2.3 Calming and Sleeping Customers
9 Global Calming and Sleeping Analyzing Market Dynamics
- 9.1 Calming and Sleeping Industry Trends
- 9.2 Calming and Sleeping Industry Drivers
- 9.3 Calming and Sleeping Industry Opportunities and Challenges
- 9.4 Calming and Sleeping Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst